Literature DB >> 11041856

CD39L2, a gene encoding a human nucleoside diphosphatase, predominantly expressed in the heart.

G Yeung1, J J Mulero, D W McGowan, S S Bajwa, J E Ford.   

Abstract

E-NTPDases are extracellular enzymes that hydrolyze nucleotides. The human E-NTPDase gene family currently consists of five reported members (CD39, CD39L1, CD39L2, CD39L3, and CD39L4). Both membrane-bound and secreted family members have been predicted by encoded transmembrane and leader peptide motifs. In this report, we demonstrate that the human CD39L2 gene is expressed predominantly in the heart. In situ hybridization results from heart indicate that the CD39L2 message is expressed in muscle and capillary endothelial cells. We also show that the CD39L2 gene encodes an extracellular E-NTPDase. Flow cytometric experiments show that transiently expressed CD39L2 is present on the surface of COS-7 cells. Transfected cells also produce recombinant glycosylated protein in the medium, and this process can be blocked by brefeldin A, an inhibitor of the mammalian secretory pathway. The enzymology of CD39L2 shows characteristic features of a typical E-NTPDase, but with a much higher degree of specificity for NDPs over NTPs as enzymatic substrates. The kinetics of the ADPase activity exhibit positive cooperativity. The predominance of CD39L2 expression in the heart supports a functional role in regulating platelet activation and recruitment in this organ.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11041856     DOI: 10.1021/bi000959z

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  The GDA1_CD39 superfamily: NTPDases with diverse functions.

Authors:  Aileen F Knowles
Journal:  Purinergic Signal       Date:  2011-01-21       Impact factor: 3.765

Review 2.  Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel.

Authors:  Frank Rutsch; Yvonne Nitschke; Robert Terkeltaub
Journal:  Circ Res       Date:  2011-08-19       Impact factor: 17.367

Review 3.  Cellular function and molecular structure of ecto-nucleotidases.

Authors:  Herbert Zimmermann; Matthias Zebisch; Norbert Sträter
Journal:  Purinergic Signal       Date:  2012-05-04       Impact factor: 3.765

4.  Expression of NTPDase1 and caveolins in human cardiovascular disease.

Authors:  Agnes Kittel; Anna L Kiss; Nándor Müllner; Ida Matkó; Beáta Sperlágh
Journal:  Histochem Cell Biol       Date:  2005-07-19       Impact factor: 4.304

5.  Characterization of an alternative splice variant of human nucleoside triphosphate diphosphohydrolase 3 (NTPDase3): a possible modulator of nucleotidase activity and purinergic signaling.

Authors:  Patrick A Crawford; Keith J Gaddie; Thomas M Smith; Terence L Kirley
Journal:  Arch Biochem Biophys       Date:  2006-11-10       Impact factor: 4.013

6.  Developmentally regulated expression of ectonucleotidases NTPDase5 and NTPDase6 and UDP-responsive P2Y receptors in the rat cochlea.

Authors:  Mary G O'Keeffe; Peter R Thorne; Gary D Housley; Simon C Robson; Srdjan M Vlajkovic
Journal:  Histochem Cell Biol       Date:  2010-03-10       Impact factor: 4.304

Review 7.  Possible effects of microbial ecto-nucleoside triphosphate diphosphohydrolases on host-pathogen interactions.

Authors:  Fiona M Sansom; Simon C Robson; Elizabeth L Hartland
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

8.  The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation.

Authors:  Gilles Kauffenstein; Cristina Ribas Fürstenau; Pedro D'Orléans-Juste; Jean Sévigny
Journal:  Br J Pharmacol       Date:  2010-01-08       Impact factor: 8.739

9.  Distribution of NTPDase5 and NTPDase6 and the regulation of P2Y receptor signalling in the rat cochlea.

Authors:  Mary G O'Keeffe; Peter R Thorne; Gary D Housley; Simon C Robson; Srdjan M Vlajkovic
Journal:  Purinergic Signal       Date:  2010-06-19       Impact factor: 3.765

10.  Phosphatase-coupled universal kinase assay and kinetics for first-order-rate coupling reaction.

Authors:  Zhengliang L Wu
Journal:  PLoS One       Date:  2011-08-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.